191 related articles for article (PubMed ID: 36142503)
1. Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection.
Caputo D; Quagliarini E; Pozzi D; Caracciolo G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142503
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle-enabled blood tests for early detection of pancreatic ductal adenocarcinoma.
Caputo D; Caracciolo G
Cancer Lett; 2020 Feb; 470():191-196. PubMed ID: 31783084
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins.
Caputo D; Coppola A; Quagliarini E; Di Santo R; Capriotti AL; Cammarata R; Laganà A; Papi M; Digiacomo L; Coppola R; Pozzi D; Caracciolo G
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230585
[TBL] [Abstract][Full Text] [Related]
4. A protein corona-enabled blood test for early cancer detection.
Caputo D; Papi M; Coppola R; Palchetti S; Digiacomo L; Caracciolo G; Pozzi D
Nanoscale; 2017 Jan; 9(1):349-354. PubMed ID: 27924334
[TBL] [Abstract][Full Text] [Related]
5. Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles.
Digiacomo L; Caputo D; Coppola R; Cascone C; Giulimondi F; Palchetti S; Pozzi D; Caracciolo G
Biointerphases; 2021 Feb; 16(1):011010. PubMed ID: 33706529
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology and pancreatic cancer management: State of the art and further perspectives.
Caputo D; Pozzi D; Farolfi T; Passa R; Coppola R; Caracciolo G
World J Gastrointest Oncol; 2021 Apr; 13(4):231-237. PubMed ID: 33889275
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Levitation of Personalized Nanoparticle-Protein Corona as an Effective Tool for Cancer Detection.
Quagliarini E; Digiacomo L; Caputo D; Coppola A; Amenitsch H; Caracciolo G; Pozzi D
Nanomaterials (Basel); 2022 Apr; 12(9):. PubMed ID: 35564106
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment.
Tarannum M; Vivero-Escoto JL
Adv Drug Deliv Rev; 2022 Aug; 187():114357. PubMed ID: 35605679
[TBL] [Abstract][Full Text] [Related]
9. Improving the accuracy of pancreatic cancer clinical staging by exploitation of nanoparticle-blood interactions: A pilot study.
Caputo D; Cartillone M; Cascone C; Pozzi D; Digiacomo L; Palchetti S; Caracciolo G; Coppola R
Pancreatology; 2018 Sep; 18(6):661-665. PubMed ID: 29914752
[TBL] [Abstract][Full Text] [Related]
10. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
[TBL] [Abstract][Full Text] [Related]
11. Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection.
Papi M; Palmieri V; Digiacomo L; Giulimondi F; Palchetti S; Ciasca G; Perini G; Caputo D; Cartillone MC; Cascone C; Coppola R; Capriotti AL; Laganà A; Pozzi D; Caracciolo G
Nanoscale; 2019 Aug; 11(32):15339-15346. PubMed ID: 31386742
[TBL] [Abstract][Full Text] [Related]
12. Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles.
Digiacomo L; Quagliarini E; La Vaccara V; Coppola A; Coppola R; Caputo D; Amenitsch H; Sartori B; Caracciolo G; Pozzi D
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680304
[TBL] [Abstract][Full Text] [Related]
13. Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.
Vellan CJ; Jayapalan JJ; Yoong BK; Abdul-Aziz A; Mat-Junit S; Subramanian P
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216204
[TBL] [Abstract][Full Text] [Related]
14. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
World J Gastroenterol; 2014 Oct; 20(38):13833-41. PubMed ID: 25320520
[TBL] [Abstract][Full Text] [Related]
15. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
Dittmar RL; Liu S; Tai MC; Rajapakshe K; Huang Y; Longton G; DeCapite C; Hurd MW; Paris PL; Kirkwood KS; Coarfa C; Maitra A; Brand RE; Killary AM; Sen S
Cancer Prev Res (Phila); 2021 Jul; 14(7):729-740. PubMed ID: 33893071
[TBL] [Abstract][Full Text] [Related]
16. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals.
Kulkarni NM; Mannelli L; Zins M; Bhosale PR; Arif-Tiwari H; Brook OR; Hecht EM; Kastrinos F; Wang ZJ; Soloff EV; Tolat PP; Sangster G; Fleming J; Tamm EP; Kambadakone AR
Abdom Radiol (NY); 2020 Mar; 45(3):729-742. PubMed ID: 31768594
[TBL] [Abstract][Full Text] [Related]
17. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
18. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease.
Kulkarni NM; Soloff EV; Tolat PP; Sangster GP; Fleming JB; Brook OR; Wang ZJ; Hecht EM; Zins M; Bhosale PR; Arif-Tiwari H; Mannelli L; Kambadakone AR; Tamm EP
Abdom Radiol (NY); 2020 Mar; 45(3):716-728. PubMed ID: 31748823
[TBL] [Abstract][Full Text] [Related]
19. Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients.
Colapicchioni V; Tilio M; Digiacomo L; Gambini V; Palchetti S; Marchini C; Pozzi D; Occhipinti S; Amici A; Caracciolo G
Int J Biochem Cell Biol; 2016 Jun; 75():180-7. PubMed ID: 26369869
[TBL] [Abstract][Full Text] [Related]
20. Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to doxorubicin.
Chen W; Zhou Y; Zhi X; Ma T; Liu H; Chen BW; Zheng X; Xie S; Zhao B; Feng X; Dang X; Liang T
Biomaterials; 2019 Feb; 192():590-600. PubMed ID: 30553134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]